Literature DB >> 35238177

Anthracene-Walled Acyclic CB[n] Receptors: in vitro and in vivo Binding Properties toward Drugs of Abuse.

Delaney DiMaggio1, Adam T Brockett2, Michael Shuster3, Steven Murkli1, Canjia Zhai1, David King1, Brona O'Dowd1, Ming Cheng1, Kimberly Brady1, Volker Briken3, Matthew R Roesch2, Lyle Isaacs1.   

Abstract

We report studies of the interaction of six acyclic CB[n]-type receptors toward a panel of drugs of abuse by a combination of isothermal titration calorimetry and 1 H NMR spectroscopy. Anthracene walled acyclic CB[n] host (M3) displays highest binding affinity toward methamphetamine (Kd =15 nM) and fentanyl (Kd =4 nM). Host M3 is well tolerated by Hep G2 and HEK 293 cells up to 100 μM according to MTS metabolic and adenylate kinase release assays. An in vivo maximum tolerated dose study with Swiss Webster mice showed no adverse effects at the highest dose studied (44.7 mg kg-1 ). Host M3 is not mutagenic based on the Ames fluctuation test and does not inhibit the hERG ion channel. In vivo efficacy studies showed that pretreatment of mice with M3 significantly reduces the hyperlocomotion after treatment with methamphetamine, but M3 does not function similarly when administered 30 seconds after methamphetamine.
© 2022 The Authors. ChemMedChem published by Wiley-VCH GmbH.

Entities:  

Keywords:  Cucurbituril; hyperlocomotion; methamphetamine; molecular recognition; sequestration agent

Mesh:

Substances:

Year:  2022        PMID: 35238177      PMCID: PMC9119912          DOI: 10.1002/cmdc.202200046

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.540


  74 in total

Review 1.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Permeable Self-Assembled Molecular Containers for Catalyst Isolation Enabling Two-Step Cascade Reactions.

Authors:  Yoshihiro Ueda; Hiroaki Ito; Daishi Fujita; Makoto Fujita
Journal:  J Am Chem Soc       Date:  2017-04-20       Impact factor: 15.419

Review 3.  Laboratory-Scale Preparative Enantioseparations of Pharmaceutically Relevant Compounds on Commercially Available Chiral Stationary Phases for HPLC.

Authors:  Roccaldo Sardella; Federica Ianni; Maura Marinozzi; Antonio Macchiarulo; Benedetto Natalini
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 4.  Biologic Approaches to Treat Substance-Use Disorders.

Authors:  Phil Skolnick
Journal:  Trends Pharmacol Sci       Date:  2015-10       Impact factor: 14.819

5.  The fluctuation test.

Authors:  B A Bridges
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

6.  In Vitro and In Vivo Sequestration of Methamphetamine by a Sulfated Acyclic CB[n]-Type Receptor.

Authors:  Adam T Brockett; Chunlin Deng; Michael Shuster; Suvenika Perera; Delaney DiMaggio; Ming Cheng; Steven Murkli; Volker Briken; Matthew R Roesch; Lyle Isaacs
Journal:  Chemistry       Date:  2021-10-27       Impact factor: 5.236

7.  A Novel Strategy to Reverse General Anesthesia by Scavenging with the Acyclic Cucurbit[n]uril-type Molecular Container Calabadion 2.

Authors:  Daniel Diaz-Gil; Friederike Haerter; Shane Falcinelli; Shweta Ganapati; Gaya K Hettiarachchi; Jeroen C P Simons; Ben Zhang; Stephanie D Grabitz; Ingrid Moreno Duarte; Joseph F Cotten; Katharina Eikermann-Haerter; Hao Deng; Nancy L Chamberlin; Lyle Isaacs; Volker Briken; Matthias Eikermann
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

8.  Acyclic CB[n]-type molecular containers: effect of solubilizing group on their function as solubilizing excipients.

Authors:  Ben Zhang; Peter Y Zavalij; Lyle Isaacs
Journal:  Org Biomol Chem       Date:  2014-04-21       Impact factor: 3.876

9.  Most efficient cocaine hydrolase designed by virtual screening of transition states.

Authors:  Fang Zheng; Wenchao Yang; Mei-Chuan Ko; Junjun Liu; Hoon Cho; Daquan Gao; Min Tong; Hsin-Hsiung Tai; James H Woods; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2008-08-19       Impact factor: 15.419

Review 10.  Recent advances in supramolecular antidotes.

Authors:  Hang Yin; Xiangjun Zhang; Jianwen Wei; Siyu Lu; David Bardelang; Ruibing Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.